Section 86 of 440
APPENDICES
Appendix C: Supplementation
Titan does not prescribe a universal supplement stack. A supplement is justified only by a clear purpose, evidence relevant to that purpose and population, an acceptable safety and interaction profile, reliable product quality, and a plan to review whether it earns its burden.
Food, medication, sleep, exercise and clinical care are not interchangeable with supplements. A product can be unnecessary, contaminated, incorrectly labelled, excessive or incompatible with a condition or medicine. “Natural”, “well studied” and “sold legally” do not mean appropriate for a particular person.
Decision pathway
Step | Required question |
|---|---|
1. Define the purpose | Is this correction of a confirmed deficiency, a clinician-directed indication, convenience nutrition, or a bounded performance use? |
2. Check alternatives | Can ordinary food, training design, sleep opportunity, equipment or treatment address the same outcome with less burden? |
3. Check evidence | Does evidence concern this product, dose, population, outcome and duration rather than a mechanism or surrogate? |
4. Check safety | Review conditions, pregnancy, age, allergies, total intake, medication and supplement interactions with a clinician or pharmacist where relevant. |
5. Check quality | Prefer products with credible independent quality testing appropriate to the jurisdiction and sport; certification reduces but does not eliminate risk. |
6. Predeclare review | Record product, batch, purpose, source, start date, direct outcome, adverse effects and stop rule. |
7. Retire when unsupported | Stop if the purpose disappears, burden exceeds benefit, evidence changes, or adverse effects occur. |
Evidence classes
Confirmed deficiency or clinical indication. Iron, vitamin D, vitamin B12 and other nutrients may be indicated for particular people, but symptoms alone do not diagnose deficiency and a population reference is not a personal target. Testing, dose and follow-up belong with qualified care. Excess intake can cause harm; for example, the NIH Office of Dietary Supplements lists an adult tolerable upper intake level of 4,000 IU/day for vitamin D from all sources unless a clinician directs otherwise.
Convenience nutrition. Protein powder can be a practical food product when ordinary meals do not meet an agreed need. It is optional, does not replace a varied diet and must fit allergy, kidney, gastrointestinal and eating-disorder considerations. Total protein targets are individual; the pooled resistance-training evidence does not create a universal 1.6-2.2 g/kg rule.
Bounded performance products. Creatine monohydrate and caffeine have evidence for selected physical or cognitive tasks in studied adults, but effect size, tolerability and suitability vary. Titan gives no universal dose. Caffeine can worsen sleep, anxiety, palpitations and gastrointestinal symptoms; EFSA notes that even 100 mg near bedtime can alter sleep in some adults, and pregnancy and other populations require different limits.
Omega-3, magnesium and multivitamin products. Evidence and indications differ by formulation, diet, outcome and population. They are not a universal foundation stack and are not treatments for inflammation, cognition, mood, sleep or cardiovascular disease unless current qualified guidance supports a specific use.
Sleep, stress and “nootropic” products. Magnesium, glycine, L-theanine, apigenin, ashwagandha, rhodiola, alpha-GPC, lion’s mane and combination stacks are not general Titan protocols. Evidence is product- and outcome-specific, quality varies, and interactions or adverse effects may occur. Persistent insomnia, anxiety, fatigue or cognitive change requires assessment rather than a stack.
Longevity and senolytic products. NMN, NR, resveratrol, quercetin, fisetin and similar products remain research or clinical topics. Mechanisms, animal data and biomarkers do not establish longer human life or a safe consumer regimen. Prescription drugs must never be repurposed for longevity without the treating clinician.
Quality and interaction safeguards
Use a pharmacist, clinician or dietitian when medication, chronic disease, pregnancy, breastfeeding, surgery, sport anti-doping rules, or multiple products make interaction or contamination consequential. Keep a complete product list with doses and brands. Avoid proprietary blends that conceal amounts and any source making disease-treatment or guaranteed-performance claims.
A serious new symptom or suspected severe reaction can require emergency help rather than routine advice. Use local emergency services for immediate danger or severe, sudden, or rapidly worsening symptoms; otherwise seek timely qualified assessment and report suspected adverse events through the relevant national system.
Titan supplement record
Status | Record only after qualified appropriateness review |
|---|---|
Record | Confirmed indication, product and batch, professional owner, interaction checks, review date, direct outcome, adverse effects, cost, and decision. |
Boundary | This record is not permission to begin a supplement. A null result and discontinuation are valid outcomes. |
No supplement is required for Core or Capability progress. A decision not to use one is not a deficit.